All tenders
75N98026P00621

THE PURPOSE OF THIS ACQUISITION IS TO PROVIDE HLA TYPING AND ANTIBODY SCREENING REAGENTS TO THE HLA LAB ON A REGULAR BASIS.

National Institutes of Health · United States

This contract has been awarded. Browse open opportunities
View Source

Time Left to Bid

Awarded

AwardedOtherFederal

Basic information

Reference number
75N98026P00621
Government level
Federal
Solicitation type
Other
Title
THE PURPOSE OF THIS ACQUISITION IS TO PROVIDE HLA TYPING AND ANTIBODY SCREENING REAGENTS TO THE HLA LAB ON A REGULAR BASIS.
Source ID
usa-75N98026P00621

Details

Location
United States

Description

THE PURPOSE OF THIS ACQUISITION IS TO PROVIDE HLA TYPING AND ANTIBODY SCREENING REAGENTS TO THE HLA LAB ON A REGULAR BASIS. Awarded to: ONE LAMBDA, INC. Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: PURCHASE ORDER

Dates

Publication
2026/06/01 12:00:00 AM UTC
Closing date
2026/09/30 12:00:00 AM UTC

Estimated value

$615K USD

Classification

Normalized category

Other

Source: USASpending (Federal)

Last updated 2026-09-02, 1:16:23 a.m.

Data refreshed every 2 hours